Skip to main content

Table 6 Summary of anchor-based and distribution-based estimates for the MCID of RS-SCs

From: Minimum clinical important difference for resilience scale specific to cancer: a prospective analysis

Scale Approach Anchor/method MCID estimate
Improvement Deterioration
RS-SC-10 Distribution S.E.M 3.51a − 3.51a
Distribution 0.5SD 4.39a − 4.39a
Linear regression QoL GHS 3.62 − 2.59
Linear regression CD-RISC-10 3.29 − 2.26
Linear regression HADS-A 3.05 − 2.61
Linear regression HADS-D 3.42 − 2.48
ROC QoL GHS 2.00 − 1.50
ROC CD-RISC-10 2.00 − 1.50
ROC HADS-A 2.00 − 1.50
ROC HADS-D 2.00 − 1.50
RS-SC-25 Distribution S.E.M 9.18 a − 9.18 a
Distribution 0.5SD 10.66 a − 10.66 a
Linear regression QoL GHS 9.31 − 6.81
Linear regression CD-RISC-10 8.56 − 6.19
Linear regression HADS-A 8.78 − 7.05
Linear regression HADS-D 8.97 − 6.79
ROC QoL-total 5.50 − 4.50
ROC CD-RISC-10 5.50 − 4.50
ROC HADS-A 5.50 − 4.50
ROC HADS-D 5.50 − 4.50
  1. a Mean